<DOC>
	<DOCNO>NCT02175238</DOCNO>
	<brief_summary>The primary objective trial investigate relative bioavailability pharmacokinetics plasma whole blood BI 691751 administer single dose without food healthy male subject .</brief_summary>
	<brief_title>Relative Bioavailability BI 691751 Administered With Without Food Healthy Male Subjects</brief_title>
	<detailed_description />
	<criteria>Inclusion criterion : 1 . Healthy male accord investigator 's assessment , base follow criterion : complete medical history include physical examination , vital sign ( Blood Pressure ( BP ) , Pulse Rate ( PR ) ) , 12lead Electrocardiogramm ( ECG ) , clinical laboratory test 2 . Age 18 50 year ( incl . ) 3 . Body Mass Index ( BMI ) 18.5 29.9 kg/m2 ( incl . ) Exclusion criterion : 1 . Any finding medical examination ( include Blood Pressure ( BP ) , Pulse Rate ( PR ) 12lead Electrocardiogramm ( ECG ) ) deviate normal judge clinically relevant investigator 2 . Repeated measurement systolic blood pressure great 140 mm Hg diastolic blood pressure great 90 mm Hg 3 . Any laboratory value outside reference range investigator considers clinical relevance 4 . Any evidence concomitant disease judge clinically relevant investigator 5 . Gastrointestinal , hepatic , renal , respiratory , cardiovascular , metabolic , immunological hormonal disorder 6 . Surgery gastrointestinal tract could interfere kinetics study drug 7 . Diseases central nervous system ( epilepsy ) , neurological disorder psychiatric disorder</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>July 2014</verification_date>
</DOC>